Related Experiment Video
Updated: Apr 9, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Stunting is associated with poor outcomes in childhood pneumonia
Peter P Moschovis1, Emmanuel O D Addo-Yobo2, Salem Banajeh3
1Massachusetts General Hospital, Boston, MA, USA.
Insights
Childhood stunting significantly increases pneumonia treatment failure and prolongs recovery. Addressing stunting in low-resource settings may improve pneumonia outcomes.
Area of Science:
- Pediatric infectious diseases
- Global child health
- Nutritional epidemiology
Background:
- Stunting affects over a quarter of children globally, with unknown impacts on childhood pneumonia outcomes.
- Childhood pneumonia remains a leading cause of mortality in low- and middle-income countries (LMICs).
Purpose of the Study:
- To evaluate the impact of stunting on treatment outcomes and recovery time in children with pneumonia.
- To analyze data from two large clinical trials involving children with severe and amoxicillin-treated pneumonia.
Main Methods:
- Analysis of data from 2542 children (aged 2-59 months) across 16 LMIC sites in two WHO/USAID-sponsored trials.
- Stunting defined as height-for-age Z-score < -2. Assessed treatment failure by day 5 and time to resolution of hypoxemic pneumonia.
Main Results:
- 28% of children were stunted. Stunted children had a higher treatment failure rate (16.0% vs. 11.5%).
- Stunting was associated with increased risk of treatment failure (adjusted RR 1.28).
- Among hypoxemic pneumonia patients, stunting correlated with slower normalization of respiratory rate and oxygen saturation.
Conclusions:
- Stunting is a significant risk factor for increased pneumonia treatment failure and prolonged recovery in children.
- Interventions to reduce childhood stunting could mitigate adverse pneumonia outcomes in resource-limited settings.
Objective:
Stunting affects 26.7% of children worldwide, and little is known about its effects on the outcomes of childhood pneumonia. We evaluated the effect of stunting on the outcomes of pneumonia among children enrolled in two large clinical trials.
Methods:
We analysed data from two WHO and USAID-sponsored inpatient treatment trials, the Severe Pneumonia Evaluation Antimicrobial Research study (n = 958) and the Amoxicillin Penicillin Pneumonia International Study (n = 1702), which enrolled children aged 2-59 months across 16 sites in LMICs. We assessed the effect of stunting (height-for-age Z score < -2) on treatment outcome and time to resolution of hypoxaemic pneumonia.
Results:
Among 2542 (96%) children with valid data for height, 28% were stunted and 12.8% failed treatment by 5 days. The failure rate among stunted patients was 16.0% vs. 11.5% among non-stunted patients [unadjusted RR = 1.24 (95% CI 1.08, 1.41); adjusted RR = 1.28 (95% CI 1.10, 1.48)]. An inverse relationship was observed between height and failure rates, even among non-stunted children. Among 845 patients with hypoxaemic pneumonia, stunting was associated with a lower probability of normalisation of respiratory rate [HR = 0.63 (95% CI 0.52, 0.75)] and oxygen saturation [HR = 0.74 (95% CI 0.61, 0.89)].
Conclusions:
Stunting increases the risk of treatment failure and is associated with a longer course of recovery in children with pneumonia. Strategies to decrease stunting may decrease the burden of adverse outcomes in childhood pneumonia in low-resource settings.
More Related Videos
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Nature and Nurture
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology